Literature DB >> 9833247

IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group.

T Witte1, K Hartung, C Sachse, T Matthias, M Fricke, H Deicher, J R Kalden, H J Lakomek, H H Peter, R E Schmidt.   

Abstract

Antibodies against dsDNA of the IgM class were measured in sera of 352 patients with systemic lupus erythematosus, 81 blood donors and 189 patients with rheumatoid arthritis using a new ELISA based on human recombinant dsDNA as antigen. IgM anti-dsDNA antibodies were found in 52.3% of the sera from patients with systemic lupus erythematosus, but in none of the sera from 81 normal controls and 189 patients with rheumatoid arthritis. The association of these autoantibodies with 31 clinical and 37 laboratory parameters was calculated. There was a highly significant negative correlation between IgM anti-dsDNA antibodies and nephritis as well as all the laboratory parameters indicating renal disease (elevated serum creatinine concentration, proteinuria, erythrocyte casts in the urine). IgM anti-dsDNA antibodies indicate protection of lupus patients against the development of lupus nephritis. Further experiments will show whether application of IgM anti-dsDNA antibodies is effective in treating lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9833247     DOI: 10.1007/s002960050063

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies.

Authors:  M R Ito; S Terasaki; E Kondo; H Shiwaku; Y Fukuoka; M Nose
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Therapeutic effect of leflunomide on the development of experimental lupus nephritis in mice.

Authors:  Chunyan He; Xuehong Lu; Zhaowei Yan; Man Wu; Shujun Liu; Yongli Yu; Ping Luo
Journal:  Rheumatol Int       Date:  2010-12-03       Impact factor: 2.631

3.  C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.

Authors:  Rama D Yammani; Marcela A Leyva; Ryan N Jennings; Karen M Haas
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

Review 4.  Are autoantibodies the targets of B-cell-directed therapy?

Authors:  David S Pisetsky; Amrie C Grammer; Tony C Ning; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2011-08-02       Impact factor: 20.543

5.  Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.

Authors:  A Mesa; J A Somarelli; W Wu; L Martinez; M B Blom; E L Greidinger; R J Herrera
Journal:  Lupus       Date:  2013-11       Impact factor: 2.911

6.  Anti-dsDNA antibodies in Brazilian patients of mainly African descent with systemic lupus erythematosus: lack of association with lupus nephritis.

Authors:  A M Atta; M M Pereira; M Santiago; M L B Sousa-Atta
Journal:  Clin Rheumatol       Date:  2009-03-13       Impact factor: 2.980

Review 7.  IgM antibodies against dsDNA in SLE.

Authors:  Torsten Witte
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

8.  B cell-intrinsic TLR9 expression is protective in murine lupus.

Authors:  Jeremy S Tilstra; Shinu John; Rachael A Gordon; Claire Leibler; Michael Kashgarian; Sheldon Bastacky; Kevin M Nickerson; Mark J Shlomchik
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

9.  Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.

Authors:  Chuancang Jiang; Julie Foley; Natasha Clayton; Grace Kissling; Micheal Jokinen; Ronald Herbert; Marilyn Diaz
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

Review 10.  Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus.

Authors:  Brendan M Giles; Susan A Boackle
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.